What You Should Know:
- Applied XL, a real-time information company tracking disruptions to the health of people, places, and the planet, today announced it had raised $3.5 million in seed funding led by Hearst Ventures with the participation of the Boston Globe Media Partners and STAT, which are owned by the Henry family.
- The latest round brings Applied XL’s total funds raised to date to $5 million in the last 12 months. The company will use the new funding to scale its first vertical
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
What You Should Know:
- Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development.
- The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner.
physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More
Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses
What You Should Know:
- Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
- Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health.
Partnership Goals
The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More
Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology
What You Should Know:
- Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers.
- Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More
Foresite Capital Raises $173M Fund for Foresite Labs Incubated Companies
What You Should Know:
- Foresite Capital is announcing their latest, oversubscribed $173M fund, which will be used to support Foresite Labs’ incubated life science companies.
- Foresite Labs was created in October 2019 to found, build, and scale life sciences companies at the intersection of healthcare and data science. One of Foresite Capital’s core beliefs is that by combining machine learning, big data, and genomics, life sciences companies can accelerate commercialization from decades
Read More
How Support Automation Enhances Clinical Trial Management
The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase.
Clinical trial teams face a multitude of competing priorities, from evaluating hundreds of potential patients to maintaining compliance and recording patient progress. No aspect or step can be neglected for a
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know:
- DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform.
- As part of the strategic agreement, Dario and Sanofi will
Read More
Selux Diagnostics Raises $50M for Next-Generation Phenotyping Platform
What You Should Know:
- Selux Diagnostics, Inc., a personalized diagnostics company to combat superbug infections and fight antibiotic resistance raises $50M in Series C financing led by RA Capital Management, with participation from Sands Capital, Schooner Capital and Northpond Ventures.
- The funding will support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform.
Precision diagnostics for
Read More
Definitive Healthcare Acquires Analytical Wizards, Healthcare Analytics Platform
What You Should Know:
- This week, Definite Healthcare announced the acquisition of Analytical Wizards, an advanced analytics company revolutionizing analytics in healthcare by combining our AI/ML-powered technology, domain expertise, and high-touch relationship model. Financial details of the acquisition were not disclosed.
- Founded in 2015, Analytical Wizards automates complex analytic models using tools that expedite efficient big data mining using artificial intelligence (AI) and
Read More
Accenture & Astellas Pharma Create Next-Generation Cloud-Based IT Core Platform
What You Should Know:
- Accenture announced it helped Astellas Pharma Inc. create a cloud-based core IT platform that serves as the foundation for an advanced, data-driven management model for the company’s global operations, which has been rolled out in the Americas, EMEA and Japan, with plans for further deployments.
- The new platform will help Astellas to rapidly incorporate new and emerging technologies; accommodate business expansions, such as
Read More
